The Indian Journal of Pediatrics

, Volume 71, Issue 2, pp 143–144

Miltefosine: An oral drug for visceral leishmaniasis

  • Rajniti Prasad
  • Ranjeet Kumar
  • B. P. Jaiswal
  • Utpal Kant Singh
Special Article

DOI: 10.1007/BF02723096

Cite this article as:
Prasad, R., Kumar, R., Jaiswal, B.P. et al. Indian J Pediatr (2004) 71: 143. doi:10.1007/BF02723096

Abstract

Miltefosine, a phosphocholine analogue originally developed as antimalignant drug, has been found to be highly active against leishmaniain vitro and animal model. 1,2 Based on these experiences this drug was tried against human visceral leishmaniasis and found to be highly effective and achieved 97% and 94% cure in phase 2 and phase 3 trial in children.

Key words

Visceral leishmaniasis (VL) Milterosine 

Copyright information

© Dr. K C Chaudhuri Foundation 2004

Authors and Affiliations

  • Rajniti Prasad
    • 3
  • Ranjeet Kumar
    • 1
    • 3
  • B. P. Jaiswal
    • 2
    • 3
  • Utpal Kant Singh
    • 2
    • 3
  1. 1.Sishu Arogya KendraPatna
  2. 2.Department of PediatricsNalanda Medical CollegePatnaIndia
  3. 3.Institute of Medical ScienceBanaras Hindu UniversityVaranasi
  4. 4.Patna

Personalised recommendations